Schedule 13G ownership disclosure

APRICUS BIOSCIENCES INC

Security class unavailable · CUSIP: 81577F109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,146,483
Percent of class
5.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-018531
Form type
SC 13G/A
Filer
SEELOS THERAPEUTICS, INC.
CIK
CIK 1017491
Filed
Feb 10, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub